Oblique Therapeutics

0 followers


Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Christer Nordstedt

Collapse
Kjell Andersson
Head of Medicinal Chemistry
Marie Scherlund
Chief Operating Officer
Mats Lindskog
Chief Business Officer
Hans-Peter Ostler
Styrelseledamot